For the year ending 2025-12-31, OPCH had -$179,941K decrease in cash & cash equivalents over the period. $217,140K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Infusion services net revenue | 5,555,778 | - | - | - |
| Other revenue | 93,741 | - | - | - |
| Total option care health revenue | 5,649,519 | - | - | - |
| Cost of net revenues - drugs | 3,984,955 | - | - | - |
| Salaries, benefits, and other employee expense | 848,996 | - | - | - |
| Other segment items | 410,124 | - | - | - |
| Depreciation and amortization expense | 67,538 | - | - | - |
| Interest expense, net | 54,558 | - | - | - |
| Total option care health revenue | - | 4,998,202 | - | - |
| Equity in earnings of joint ventures | 7,409 | - | - | - |
| Cost of net revenues - drugs | - | 3,446,735 | - | - |
| Other, net | -7,857 | - | - | - |
| Salaries, benefits, and other employee expense | - | 787,922 | - | - |
| Other segment items | - | 380,803 | - | - |
| Depreciation and amortization expense | - | 60,909 | - | - |
| Interest expense, net | - | 49,029 | - | - |
| Equity in earnings of joint ventures | - | 5,964 | - | - |
| Other, net | - | 4,831 | - | - |
| Income tax expense | 75,315 | 71,776 | - | - |
| Net income | 207,585 | 211,823 | 267,090 | 150,556 |
| Depreciation and amortization expense | 70,690 | 63,498 | 62,200 | 65,434 |
| Non-cash operating lease costs | 25,008 | 22,581 | 18,533 | 19,713 |
| Deferred income taxes, net | 8,443 | 12,656 | 12,766 | 49,187 |
| Gain on sale of assets | - | 0 | 0 | 9,403 |
| Loss on extinguishment of debt | -4,744 | -377 | 0 | 0 |
| Amortization of deferred financing costs | 4,147 | 4,628 | 4,446 | 4,304 |
| Loss on interest rate swaps upon discontinuing hedge accounting | - | - | - | 0 |
| Paid-in-kind interest capitalized as principal | - | - | - | 0 |
| Equity in earnings of joint ventures | 7,409 | 5,964 | 5,530 | 5,125 |
| Stock-based incentive compensation expense | 39,956 | 36,143 | 30,479 | 16,783 |
| Distribution from equity method investments | 4,000 | 2,400 | 4,000 | 5,875 |
| Change in contingent consideration liability | - | - | - | 0 |
| Other adjustments | 1,033 | -4,504 | -1,244 | 0 |
| Accounts receivable, net | 54,593 | 32,075 | -224 | 36,889 |
| Inventories | 81,469 | 114,127 | 51,000 | 41,010 |
| Prepaid expenses and other current assets | -17,756 | 15,601 | 6,290 | 16,798 |
| Accounts payable | 19,523 | 183,395 | 47,703 | 98,885 |
| Accrued compensation and employee benefits | 6,292 | -29,480 | 15,546 | -7,770 |
| Accrued expenses and other current liabilities | 9,894 | 6,133 | -1,727 | 10,535 |
| Operating lease liabilities | 24,034 | 21,911 | 17,529 | 21,395 |
| Other noncurrent assets and liabilities | -6,881 | -3,420 | 8,372 | 15,335 |
| Net cash provided by operating activities | 258,447 | 323,392 | 371,295 | 267,547 |
| Acquisition of property and equipment | 41,307 | 35,606 | 41,866 | 35,358 |
| Proceeds from sale of assets | 0 | 0 | 3,743 | 14,670 |
| Business acquisitions, net of cash acquired | 117,247 | 0 | 12,494 | 87,364 |
| Other investing activities | 2,529 | 864 | 5,889 | 0 |
| Net cash used in investing activities | -161,083 | -36,470 | -56,506 | -108,052 |
| Exercise of stock options, vesting of restricted stock, and related tax withholdings | - | - | -3,115 | 352 |
| Stock-based compensation tax withholdings | 10,599 | 12,382 | - | - |
| Net proceeds from issuance of common stock | - | - | - | 0 |
| Purchase of company stock and related excise taxes | 309,951 | 252,726 | 250,261 | - |
| Proceeds from warrant exercises | - | 0 | 0 | 20,916 |
| Proceeds from issuance of debt | 229,472 | 49,959 | 0 | 0 |
| Repayments of debt principal | 4,951 | 6,384 | 6,000 | 6,000 |
| Retirement of debt obligations | 180,239 | - | 0 | 0 |
| Deferred financing costs | 3,382 | 77 | 0 | 0 |
| Debt prepayment fees | - | - | 0 | 0 |
| Other financing activities | 2,345 | 3,404 | -5,750 | - |
| Net cash used in financing activities | -277,305 | -218,206 | -265,126 | 15,268 |
| Net (decrease) increase in cash and cash equivalents | -179,941 | 68,716 | 49,663 | 174,763 |
| Cash and cash equivalents - beginning of period | 412,565 | 343,849 | 294,186 | 119,423 |
| Cash and cash equivalents - end of period | 232,624 | 412,565 | 343,849 | 294,186 |
Option Care Health, Inc. (OPCH)
Option Care Health, Inc. (OPCH)